On our screens:Cheap stocks by free cash flow yield
What is the market doing?
What the tape says about BMY
Bristol Myers Squibb is +39% over the past year while the S&P 500 is +20%: 19 points ahead of the market.
+39%
1-year return · S&P 500 +20%
- vs 200-day average
- +14%
vs 200-day average · a clear uptrend
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- 4.6%
Below its 52-week high
Details›
- Last close2026-09-08
- $64.93
- 1 monthS&P 500 −0.30%
- +1.2%
- 1 yearS&P 500 +20%
- +39%
- 5 yearsS&P 500 +85%
- +17%
- vs 50-day average$62.00
- +4.7%
- 52-week high
- $68.08
- 52-week low
- $41.67
- Annualised volatility
- 28%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$1.9M
| Year | Return |
|---|---|
| 2026 (year to date) | +23% |
| 2025 | +0.11% |
| 2024 | +16% |
| 2023 | −26% |
| 2022 | +19% |
| 2021 | +2.9% |
| 2020 | +0.41% |
| 2019 | +28% |
| 2018 | −13% |
| 2017 | +7.7% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | −0.72% |
| Feb | 10 | 7 of 10 | +3.8% |
| Mar | 10 | 5 of 10 | −0.41% |
| Apr | 10 | 4 of 10 | −4.0% |
| May | 10 | 3 of 10 | −2.1% |
| Jun | 10 | 5 of 10 | +0.37% |
| Jul | 11 | 7 of 11 | +3.1% |
| Aug | 11 | 7 of 11 | +0.76% |
| Sep | 11 | 5 of 11 | −0.96% |
| Oct | 10 | 4 of 10 | −0.32% |
| Nov | 10 | 7 of 10 | +2.9% |
| Dec | 10 | 6 of 10 | +2.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - General
The closest names by size in the same industry